[1] 罗观文,梁栋立,洪好武,等. Rh阴性抗-D人免疫球蛋白的研究进展[J]. 华西药学杂志,2019,34(2):179-182. [2] 李翠莹. 胎儿新生儿溶血病的诊疗策略探讨[J]. 临床输血与检验,2021,23(1):24-28. [3] 中国输血协会免疫血液学专业委员会. 胎儿新生儿溶血病实验室检测专家共识[J]. 临床输血与检验,2021,23(1):20-23. [4] 尚红,王毓三,申子瑜,等.全国临床检验操作规程[M].第4版.北京:人民卫生出版社,2015:118-124. [5] 林园. 新生儿溶血病(HDN)免疫血液学试验推荐方案[J]. 中国输血杂志,2012,25(2):95-100. [6] 李志强. RhD抗原阴性孕产妇血液安全管理专家共识[J]. 中国输血杂志,2017,30(10):1085-1091. [7] 吴俊杰,洪小珍,马开荣,等. 浙江汉族DEL表型基因分型方法的建立[J]. 中国实验血液学杂志,2006,14(5):1017-1019. [8] Mark K. Fung,Brenda J.Grossman,Christoper D.Hillyer,等主编,桂嵘,陈秉宇,黄远帅,等主译.AABB技术手册[M].第18版.长沙:中南大学出版社,2019:379-382. [9] 范秀,肖军,李翠莹. 抗-D免疫球蛋白预防RhD血型不合胎儿新生儿溶血病的研究进展[J]. 临床输血与检验,2021,23(1):29-32. [10] 章旭,林凤秋,李剑平,等. DEL型个体抗体筛选的调查分析[J]. 中国输血杂志,2009,22(10):796-799. [11] 莫春妍,廖志坚,张润青,等. 红细胞不规则抗体致新生儿溶血病血清学特征分析[J]. 中华新生儿科杂志,2021,36(1):55-58. [12] DE HAAS M,THURIK F F,KOELEWIJN J M,et al.Haemolytic disease of the fetus and newborn[J]. Vox Sang,2015,109(2):99-113. [13] BRITISH Committee for Standards in Haematology,MILKINS C,BERRYMAN J,et al. Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. British Committee for Standards in Haematology[J]. Transfus Med,2013,23(1):3-35. [14] ROYAL COLLEGE OF OBSTETRICIANS AND GYNAECOLOGISTS(RCOG). Green-top guideline no. 65:the management of women with red cell antibodies during pregnancy[J]. Obstet Gynecol,2014,16(3):224. [15] WHITE J,QURESHI H,MASSEY E,et al.Guideline for blood grouping and red cell antibody testing in pregnancy[J]. Transfus Med,2016,26(4):246-263. [16] QURESHI H,MASSEY E,KIRWAN D,et al.BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn[J]. Transfus Med,2014,24(1):8-20. [17] 吴远军,隗伏冰,杨勇. 胎儿及新生儿免疫溶血性疾病研究进展[J]. 中华围产医学杂志,2020,23(1):44-51. |